Status:
COMPLETED
A Study of Minirin Melt in Patients With Nocturia
Lead Sponsor:
Ferring Pharmaceuticals
Conditions:
Nocturia
Eligibility:
All Genders
18-64 years
Brief Summary
This is a confirmation of safety profile for Minirin Melt in clinical practice.
Eligibility Criteria
Inclusion
- nocturia
Exclusion
- habitual or psychogenic polydipsia
- known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics
- moderate and severe renal insufficiency
- know hyponatremia
- syndrome of inappropriate ADH secretion
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
2187 Patients enrolled
Trial Details
Trial ID
NCT01212224
Start Date
January 1 2010
End Date
December 1 2013
Last Update
January 6 2014
Active Locations (81)
Enter a location and click search to find clinical trials sorted by distance.
1
Nemocnice Rudolfa a Stefanie
Benešov, Czechia
2
Private ambulance Benešov
Benešov, Czechia
3
Private ambulance Beroun
Beroun, Czechia
4
Private ambulance - Slezská urologie, s.r.o.
Bohumín, Czechia